262 related articles for article (PubMed ID: 1511019)
1. Bone metastases and tumor-induced hypercalcemia.
Body JJ
Curr Opin Oncol; 1992 Aug; 4(4):624-31. PubMed ID: 1511019
[TBL] [Abstract][Full Text] [Related]
2. Medical treatment of tumor-induced hypercalcemia and tumor-induced osteolysis: challenges for future research.
Body JJ
Support Care Cancer; 1993 Jan; 1(1):26-33. PubMed ID: 8143098
[TBL] [Abstract][Full Text] [Related]
3. Clinical trials in metastatic breast cancer to bone: past--present--future.
Body JJ
Can J Oncol; 1995 Dec; 5 Suppl 1():16-27. PubMed ID: 8853520
[TBL] [Abstract][Full Text] [Related]
4. [Bone metastases: pathogenesis and treatment with diphosphonates].
Body JJ
Bull Mem Acad R Med Belg; 1997; 152(3):169-74; discussion 174-6. PubMed ID: 9491638
[TBL] [Abstract][Full Text] [Related]
5. [Osteolytic metastases of breast cancer and biphosphonates].
Lortholary A; Alleaume C; Pein F; Larra F
Rev Med Interne; 1992; 13(3):238-42. PubMed ID: 1410908
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates in the treatment of malignant bone disease.
Berenson JR; Lipton A
Annu Rev Med; 1999; 50():237-48. PubMed ID: 10073275
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates for cancer patients: why, how, and when?
Body JJ; Mancini I
Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
[TBL] [Abstract][Full Text] [Related]
8. Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone.
Coukell AJ; Markham A
Drugs Aging; 1998 Feb; 12(2):149-68. PubMed ID: 9509293
[TBL] [Abstract][Full Text] [Related]
9. Use of bisphosphonates in cancer patients.
Body JJ; Coleman RE; Piccart M
Cancer Treat Rev; 1996 Jul; 22(4):265-87. PubMed ID: 9025784
[No Abstract] [Full Text] [Related]
10. Hypercalcemia and bone resorption in malignancy.
Walls J; Bundred N; Howell A
Clin Orthop Relat Res; 1995 Mar; (312):51-63. PubMed ID: 7634618
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of markers of bone resorption in patients with breast cancer-induced osteolysis before and after bisphosphonate therapy.
Body JJ; Dumon JC; Gineyts E; Delmas PD
Br J Cancer; 1997; 75(3):408-12. PubMed ID: 9020487
[TBL] [Abstract][Full Text] [Related]
12. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
Body JJ; Bartl R; Burckhardt P; Delmas PD; Diel IJ; Fleisch H; Kanis JA; Kyle RA; Mundy GR; Paterson AH; Rubens RD
J Clin Oncol; 1998 Dec; 16(12):3890-9. PubMed ID: 9850035
[TBL] [Abstract][Full Text] [Related]
13. Treatment of tumor-induced osteolysis by APD.
Burckhardt P; Thiébaud D; Perey L; von Fliedner V
Recent Results Cancer Res; 1989; 116():54-66. PubMed ID: 2762665
[TBL] [Abstract][Full Text] [Related]
14. Rationale for the use of bisphosphonates in bone metastases.
Kanis JA; McCloskey EV; Taube T; O'Rourke N
Bone; 1991; 12 Suppl 1():S13-8. PubMed ID: 1954047
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of action of bisphosphonates on tumor cells and prospects for use in the treatment of malignant osteolysis.
Clézardin P; Gligorov J; Delmas P
Joint Bone Spine; 2000 Jan; 67(1):22-9. PubMed ID: 10773965
[TBL] [Abstract][Full Text] [Related]
16. Hypercalcemia of malignancy.
Body JJ
Semin Nephrol; 2004 Jan; 24(1):48-54. PubMed ID: 14730509
[TBL] [Abstract][Full Text] [Related]
17. [Bone targeting agents: bisphosphonates].
Debiais F
Bull Cancer; 2013 Nov; 100(11):1199-206. PubMed ID: 24158668
[TBL] [Abstract][Full Text] [Related]
18. [From laundry product to cancer drug--history of a drug class].
Possinger K
Med Klin (Munich); 2000 Oct; 95 Suppl 2():3-7. PubMed ID: 11089381
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group.
Hortobagyi GN; Theriault RL; Porter L; Blayney D; Lipton A; Sinoff C; Wheeler H; Simeone JF; Seaman J; Knight RD
N Engl J Med; 1996 Dec; 335(24):1785-91. PubMed ID: 8965890
[TBL] [Abstract][Full Text] [Related]
20. The role of bisphosphonates in the treatment of bone metastases--the U.S. experience.
Harvey HA; Lipton A
Support Care Cancer; 1996 May; 4(3):213-7. PubMed ID: 8739655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
